RecruitingNot applicableNCT05936086
A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH
Studying Hemophagocytic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- shifeng Lou
- Principal Investigator
- Qing Wen, doctorHematology Medical Center, the Second Affiliated Hospital of PLA Army Medical University
- Intervention
- Cytoxan(drug)
- Enrollment
- 160 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- The Second affiliated Hosptial of Chongqing medical University, Chongqing, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05936086 on ClinicalTrials.govOther trials for Hemophagocytic syndrome
Additional recruiting or active studies for the same condition.